Production of therapeutic proteins in the chloroplast of Chlamydomonas reinhardtii

Alma Lorena Almaraz-Delgado; José Flores-Uribe; Víctor Hugo Pérez-España; Edgar Salgado-Manjarrez; Jesús Agustín Badillo-Corona

doi:10.1186/s13568-014-0057-4

Production of therapeutic proteins in the chloroplast of Chlamydomonas reinhardtii

Alma Lorena Almaraz-Delgado, José Flores-Uribe, Víctor Hugo Pérez-España, Edgar Salgado-Manjarrez, Jesús Agustín Badillo-Corona

Unidad Profesional Interdisciplinaria de Biotecnología (UPIBI)

Research output: Contribution to journal › Article › peer-review

57 Scopus citations

Abstract

Chloroplast transformation in the photosynthetic alga Chlamydomonas reinhardtii has been used to explore the potential to use it as an inexpensive and easily scalable system for the production of therapeutic recombinant proteins. Diverse proteins, such as bacterial and viral antigens, antibodies and, immunotoxins have been successfully expressed in the chloroplast using endogenous and chimeric promoter sequences. In some cases, proteins have accumulated to high level, demonstrating that this technology could compete with current production platforms. This review focuses on the works that have engineered the chloroplast of C. reinhardtii with the aim of producing recombinant proteins intended for therapeutical use in humans or animals.

Original language	English
Article number	57
Pages (from-to)	1-9
Number of pages	9
Journal	AMB Express
Volume	4
Issue number	1
DOIs	https://doi.org/10.1186/s13568-014-0057-4
State	Published - 1 Dec 2014

Keywords

Chlamydomonas
Chloroplast transformation
Recombinant therapeutic proteins

Access to Document

10.1186/s13568-014-0057-4

Cite this

@article{56185c025d9c40a8b8c19f40d4d39bf1,

title = "Production of therapeutic proteins in the chloroplast of Chlamydomonas reinhardtii",

abstract = "Chloroplast transformation in the photosynthetic alga Chlamydomonas reinhardtii has been used to explore the potential to use it as an inexpensive and easily scalable system for the production of therapeutic recombinant proteins. Diverse proteins, such as bacterial and viral antigens, antibodies and, immunotoxins have been successfully expressed in the chloroplast using endogenous and chimeric promoter sequences. In some cases, proteins have accumulated to high level, demonstrating that this technology could compete with current production platforms. This review focuses on the works that have engineered the chloroplast of C. reinhardtii with the aim of producing recombinant proteins intended for therapeutical use in humans or animals.",

keywords = "Chlamydomonas, Chloroplast transformation, Recombinant therapeutic proteins",

author = "Almaraz-Delgado, {Alma Lorena} and Jos{\'e} Flores-Uribe and P{\'e}rez-Espa{\~n}a, {V{\'i}ctor Hugo} and Edgar Salgado-Manjarrez and Badillo-Corona, {Jes{\'u}s Agust{\'i}n}",

note = "Publisher Copyright: {\textcopyright} 2014, Almaraz Delgado et al.; licensee Springer.",

year = "2014",

month = dec,

day = "1",

doi = "10.1186/s13568-014-0057-4",

language = "Ingl{\'e}s",

volume = "4",

pages = "1--9",

journal = "AMB Express",

issn = "2191-0855",

number = "1",

}

TY - JOUR

T1 - Production of therapeutic proteins in the chloroplast of Chlamydomonas reinhardtii

AU - Almaraz-Delgado, Alma Lorena

AU - Flores-Uribe, José

AU - Pérez-España, Víctor Hugo

AU - Salgado-Manjarrez, Edgar

AU - Badillo-Corona, Jesús Agustín

PY - 2014/12/1

Y1 - 2014/12/1

N2 - Chloroplast transformation in the photosynthetic alga Chlamydomonas reinhardtii has been used to explore the potential to use it as an inexpensive and easily scalable system for the production of therapeutic recombinant proteins. Diverse proteins, such as bacterial and viral antigens, antibodies and, immunotoxins have been successfully expressed in the chloroplast using endogenous and chimeric promoter sequences. In some cases, proteins have accumulated to high level, demonstrating that this technology could compete with current production platforms. This review focuses on the works that have engineered the chloroplast of C. reinhardtii with the aim of producing recombinant proteins intended for therapeutical use in humans or animals.

AB - Chloroplast transformation in the photosynthetic alga Chlamydomonas reinhardtii has been used to explore the potential to use it as an inexpensive and easily scalable system for the production of therapeutic recombinant proteins. Diverse proteins, such as bacterial and viral antigens, antibodies and, immunotoxins have been successfully expressed in the chloroplast using endogenous and chimeric promoter sequences. In some cases, proteins have accumulated to high level, demonstrating that this technology could compete with current production platforms. This review focuses on the works that have engineered the chloroplast of C. reinhardtii with the aim of producing recombinant proteins intended for therapeutical use in humans or animals.

KW - Chlamydomonas

KW - Chloroplast transformation

KW - Recombinant therapeutic proteins

UR - http://www.scopus.com/inward/record.url?scp=84929048742&partnerID=8YFLogxK

U2 - 10.1186/s13568-014-0057-4

DO - 10.1186/s13568-014-0057-4

M3 - Artículo

C2 - 25136510

SN - 2191-0855

VL - 4

SP - 1

EP - 9

JO - AMB Express

JF - AMB Express

IS - 1

M1 - 57

ER -

Production of therapeutic proteins in the chloroplast of Chlamydomonas reinhardtii

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this